Disease Overview：Secondary hypertension（SH）
Secondary hypertension is a form of high blood pressure caused by an underlying, identifiable condition—such as renal artery stenosis, primary aldosteronism, pheochromocytoma, Cushing’s syndrome, or coarctation of the aorta—rather than arising from multifactorial, idiopathic causes. Unlike essential hypertension, secondary hypertension often presents earlier (before age 30 or after age 55), with abrupt onset, severe or resistant blood pressure elevation (>140/90 mmHg despite ≥3 antihypertensive agents), or associated clinical clues like hypokalemia, episodic palpitations, or abdominal bruits. Accurate diagnosis requires systematic evaluation: hormonal assays (e.g., plasma renin activity, aldosterone-to-renin ratio), imaging (renal Doppler ultrasound, adrenal CT/MRI), and functional testing (e.g., clonidine suppression test). Timely intervention—whether pharmacologic, endovascular (e.g., renal artery stenting), or surgical (e.g., adrenalectomy for aldosteronoma)—can normalize blood pressure and prevent end-organ damage including left ventricular hypertrophy, chronic kidney disease, and stroke.
China offers distinct advantages in managing secondary hypertension: leading cardiovascular centers—such as Fuwai Hospital (National Center for Cardiovascular Diseases) and Shanghai Ruijin Hospital—combine deep subspecialty expertise in hypertension phenotyping with cutting-edge technology, including 3T MRI for adrenal vein sampling, robotic-assisted laparoscopic adrenalectomy, and AI-enhanced hemodynamic modeling. Success rates for curable forms (e.g., unilateral primary aldosteronism) exceed 70% post-intervention, with robust 5-year remission data published in journals like *Hypertension* and *Journal of the American College of Cardiology*. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising diagnostic rigor or procedural standards. As a dedicated medical tourism agency, we facilitate seamless international care—vetting accredited hospitals, coordinating multidisciplinary evaluations, providing transparent all-inclusive pricing, and offering end-to-end support from visa assistance to post-discharge follow-up.
Secondary hypertension: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Secondary Hypertension (Cardiovascular Department)
Non-Surgical / Conservative Management
*Target Criteria:* Confirmed secondary cause (e.g., renal artery stenosis, primary aldosteronism, pheochromocytoma, Cushing’s syndrome) with mild–moderate hemodynamic impact; stable organ function; contraindications or patient refusal for intervention.
- •Diagnostic Workup (Pre-Treatment)
- Plasma renin activity + aldosterone (ARR): $35–$50 - 24-hr urinary metanephrines: $75–$95 - Cortisol rhythm (8 AM/4 PM salivary cortisol + DST): $60–$85 - Contrast-enhanced CT angiography (renal/adrenal): $180–$240
- •Pharmacotherapy (Monthly, Tiered)
- *Tier 2 (Add-on control)*: Calcium channel blockers, beta-blockers, low-dose thiazides: $8–$18 - *Tier 3 (Resistant cases)*: Hydralazine + isosorbide dinitrate, clonidine: $15–$30
Surgical / Interventional Procedures
*Eligibility Criteria:* Hemodynamically significant unilateral adrenal adenoma (confirmed by AV sampling), >70% renal artery stenosis with hypertension uncontrolled on ≥3 drugs + renal impairment, biochemically confirmed pheochromocytoma with resectable tumor.
- •Adrenalectomy (Laparoscopic, PA or Pheo)
- Procedure + anesthesia + 3-day hospital stay: $2,800–$3,600
- •Renal Artery Stenting (Endovascular)
- Procedure (stent + angiography + 2-day admission): $3,100–$4,200
- •Bilateral Adrenal Vein Sampling (AVS)
Special/Complex Condition Management
- •Fibromuscular dysplasia (FMD)-related RAS: Medical therapy preferred; angioplasty only if refractory: $2,400–$3,300
- •Coarctation of aorta (adult presentation): Cardiac MRI + catheter-based stenting: $4,800–$6,200
- •Malignant hypertension with acute kidney injury: ICU admission + IV nicardipine/labetalol + dialysis support: $1,200–$2,000/day
Quick Selection Guide
- •<45 years, confirmed unilateral aldosteronism, no comorbidities: Laparoscopic adrenalectomy ($3,200 avg) — curative intent, optimal long-term cost.
- •65+ years, bilateral RAS + CKD stage 3, limited mobility: Optimized medical therapy ($20–$45/month) — avoids procedural risk; monitor eGFR quarterly.
- •Budget-constrained (<$500 total): Prioritize ARR + renal Doppler ($80–$115) to confirm PA or RAS; initiate spironolactone or ACEi ($12–$25/month) while deferring imaging.
- •Severe resistant HTN + acute LV dysfunction: Urgent cardiac echo + renal angiography ($275) → proceed to stenting ($3,650 avg) if >70% stenosis confirmed.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Secondary hypertension Medical Vacation Packages
Curated transparent all-inclusive packages combining Secondary hypertension treatment with China top medical destinations:
